Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras

Core Viewpoint - Exosens has entered into exclusive negotiations to acquire Noxant, a company specializing in high-performance cooled infrared cameras, which is expected to enhance Exosens' technology platform and expand its product offerings in the infrared imaging sector [1][2][3]. Company Overview - Exosens is a high-tech company with over 85 years of experience in the innovation, development, manufacturing, and sale of high-end electro-optical technologies, including amplification, detection, and imaging solutions [8][9]. - The company is listed on Euronext Paris and is recognized as a major innovator in optoelectronics, with over 1,700 employees and production and R&D facilities across 11 sites in Europe and North America [9]. Acquisition Details - The acquisition of Noxant is part of Exosens' growth strategy and follows three other transactions since its IPO in June 2024, which included Centronic (UK), LR Tech (Canada), and NVLS (Spain) [7]. - Noxant generated approximately EUR 12 million in revenue for the financial year ending June 30, 2024, and has 22 employees [6]. Strategic Synergies - The acquisition is expected to create significant synergies between Noxant and Exosens' existing imaging business, particularly with Telops, which was acquired in 2023 [1][3][4]. - Noxant's expertise in cooled infrared technology aligns with Exosens' mission to deliver high-performance imaging solutions, enhancing R&D capabilities and accelerating innovation in infrared technologies [3][4]. Market Positioning - Noxant serves various applications, including surveillance, scientific research, industrial testing, and gas detection, making it a complementary addition to Exosens' infrared offerings [2][4]. - The combined capabilities of Exosens and Noxant are expected to meet the growing demand for advanced infrared solutions, particularly in drone-based and industrial control applications [4].